Hepatitis B Virus Screening and Potential Reactivation in Patients Undergoing Treatment for Cancer

被引:3
作者
Hammond, Sarah P. [1 ,2 ,3 ]
Swaminathan, Sankar [4 ]
Bensinger, William I. [5 ]
Baden, Lindsey R. [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
[2] Brigham & Womens Hosp, Clin Fac, Div Infect Dis, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Univ Utah, Salt Lake City, UT 84112 USA
[5] Fred Hutchinson Canc Res Ctr, Autologous Stem Cell Transplant Program, Seattle, WA USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2014年 / 12卷 / 12期
关键词
RECEIVING CYTOTOXIC CHEMOTHERAPY; PREVENTION; LAMIVUDINE; INFECTION;
D O I
10.6004/jnccn.2014.0166
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1655 / 1657
页数:3
相关论文
共 21 条
  • [1] [Anonymous], WKLY EPIDEMIOL REC
  • [2] [Anonymous], VIR HEP STAT SURV
  • [3] American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
    Artz, Andrew S.
    Somerfield, Mark R.
    Feld, Jordan J.
    Giusti, Andrew F.
    Kramer, Barnett S.
    Sabichi, Anita L.
    Zon, Robin T.
    Wong, Sandra L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3199 - 3202
  • [4] Prevention and Treatment of Cancer-Related Infections
    Baden, Lindsey Robert
    Bensinger, William
    Angarone, Michael
    Casper, Corey
    Dubberke, Erik R.
    Freifeld, Alison G.
    Garzon, Ramiro
    Greene, John N.
    Greer, John P.
    Ito, James I.
    Karp, Judith E.
    Kaul, Daniel R.
    King, Earl
    Mackler, Emily
    Marr, Kieren A.
    Montoya, Jose G.
    Morris-Engemann, Ashley
    Pappas, Peter G.
    Rolston, Ken
    Segal, Brahm
    Seo, Susan K.
    Swaminathan, Sankar
    Naganuma, Maoko
    Shead, Dorothy A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (11): : 1412 - 1445
  • [5] Centers for Disease Control and Prevention, 2012, SURV VIR HEP US
  • [6] Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation
    Hammond, Sarah P.
    Borchelt, Anne Marie
    Ukomadu, Chinweike
    Ho, Vincent T.
    Baden, Lindsey R.
    Marty, Francisco M.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1049 - 1059
  • [7] Hepatitis B virus management to prevent reactivation after chemotherapy: a review
    Hwang, Jessica P.
    Vierling, John M.
    Zelenetz, Andrew D.
    Lackey, Susan C.
    Loomba, Rohit
    [J]. SUPPORTIVE CARE IN CANCER, 2012, 20 (11) : 2999 - 3008
  • [8] Hepatitis B virus reactivation and alemtuzumab therapy
    Iannitto, E
    Minardi, V
    Calvaruso, G
    Mulè, A
    Ammatuna, E
    Trapani, RD
    Ferraro, D
    Abbadessa, V
    Craxí, A
    Stefano, RD
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (03) : 254 - 258
  • [9] Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review
    Kang, Byung Woog
    Lee, Soo Jung
    Moon, Joon Ho
    Kim, Shi-Nae
    Chae, Yee Soo
    Kim, Jong Gwang
    Hwang, Yoon-Jin
    Sohn, Sang-Kyun
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (03) : 383 - 387
  • [10] Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: US Preventive Services Task Force Recommendation Statement
    LeFevre, Michael L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (01) : 58 - +